A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Enprofylline
Lopinavir
The serum concentration of Mitoxantrone can be increased when it is combined with Lopinavir.
Enprofylline
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Mitoxantrone.
Enprofylline
Tafamidis
The serum concentration of Mitoxantrone can be increased when it is combined with Tafamidis.
Enprofylline
Levamlodipine
The serum concentration of Levamlodipine can be increased when it is combined with Mitoxantrone.
Enprofylline
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Mitoxantrone.
Enprofylline
Lasmiditan
The serum concentration of Mitoxantrone can be increased when it is combined with Lasmiditan.
Enprofylline
Entrectinib
The metabolism of Entrectinib can be decreased when combined with Mitoxantrone.
Enprofylline
Propacetamol
Mitoxantrone may increase the hepatotoxic activities of Propacetamol.
Enprofylline
Prucalopride
The metabolism of Prucalopride can be decreased when combined with Mitoxantrone.
Enprofylline
Tedizolid phosphate
The risk or severity of myelosuppression can be increased when Mitoxantrone is combined with Tedizolid phosphate.
Enprofylline
Cyclopenthiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Mitoxantrone.
Enprofylline
Mebutizide
The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Mitoxantrone.
Enprofylline
Polythiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Mitoxantrone.
Enprofylline
Trichlormethiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Mitoxantrone.
Enprofylline
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Mitoxantrone.
Enprofylline
Edetic acid
The risk or severity of bleeding can be increased when Edetic acid is combined with Mitoxantrone.
Enprofylline
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Mitoxantrone.
Enprofylline
Clorindione
The risk or severity of bleeding can be increased when Clorindione is combined with Mitoxantrone.
Enprofylline
Fluindione
The risk or severity of bleeding can be increased when Fluindione is combined with Mitoxantrone.
Enprofylline
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Mitoxantrone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3